| Article | Date | Source |
|---|
| Alkermes (ALKS) Reports First Quarter Fiscal | -- | Biotechnology - Moreover |
| Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013 | May 17, 2012 | Pharma News - Business Wire |
| Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2012 | May 10, 2012 | Pharma News - Business Wire |
| Elan Corporation PLC Raises $381 Million in Sale of 76% of Alkermes plc | March 13, 2012 | BioSpace - Breaking News |
| Elan Raises $381 Million in Sale of 76% of Alkermes Holding | March 13, 2012 | Biotech News - Business Wire |
| Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan | March 13, 2012 | Pharma News - Business Wire |
| Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan | March 08, 2012 | Pharma News - Business Wire |
| Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan | March 07, 2012 | Pharma News - Business Wire |
| Alkermes plc Files Resale Shelf Registration in Connection with Elan Corporation PLC Shareholder Agreement | February 17, 2012 | BioSpace - Breaking News |
| Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement | February 16, 2012 | Pharma News - Business Wire |
| FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News | February 03, 2012 | Xconomy Life Sciences |
| Alkermes plc Reports Third Quarter Fiscal 2012 Financial Results | February 02, 2012 | Pharma News - Business Wire |
| Alkermes plc Initiates Open-Label Pilot Study of VIVITROL?? to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence | January 31, 2012 | BioSpace - Breaking News |
| Alkermes Initiates Open-Label Pilot Study of VIVITROL® to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence | January 31, 2012 | Pharma News - Business Wire |
| FDA Approves Amylin Pharmaceuticals, Inc. and Alkermes plc's BYDUREON??? -- The First and Only Once-Weekly Treatment for Type 2 Diabetes | January 30, 2012 | BioSpace |
| Alkermes plc to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2012 | January 27, 2012 | BioSpace - Breaking News |
| Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2012 | January 26, 2012 | Pharma News - Business Wire |
| Alkermes plc Announces Positive Results From Clinical Study of ALKS 5461 for Major Depressive Disorder | January 04, 2012 | BioSpace - Breaking News |
| Alkermes Announces Positive Results From Clinical Study of ALKS 5461 for Major Depressive Disorder | January 04, 2012 | Pharma News - Business Wire |
| Alkermes sets Phase 3 clinical drug trial | December 20, 2011 | Health News - BizJournals.com |
| Alkermes plc Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia | December 19, 2011 | BioSpace - Breaking News |
| Alkermes advances schizophrenia drug candidate | December 19, 2011 | Health News - BizJournals.com |
| Alkermes Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia | December 19, 2011 | Pharma News - Business Wire |
| Alkermes Contract Pharma Services | December 17, 2011 | Pharmaceutical - Moreover |
| Infinity Adds $50M, Idera Nabs Drug Rights, Alkermes Spinout Civitas Gets Grant, & More Boston-Area Life Sciences News | December 02, 2011 | Xconomy Life Sciences |
| Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug | November 29, 2011 | Xconomy Life Sciences |
| Alkermes Cut to Neutral | November 15, 2011 | Pharmaceutical - Moreover |
| Alkermes Cut to Neutral - Analyst Blog | November 15, 2011 | Pharmaceutical - Moreover |
| Alkermes plc Release: New Long-Term Data on VIVITROL?? Showed Sustained Efficacy and Safety over 18 Months of Treatment | November 09, 2011 | BioSpace - Breaking News |
| Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact | November 08, 2011 | Xconomy Life Sciences |
| Alkermes fiscal 2nd-quarter loss widens | November 03, 2011 | Health News - CNBC |
| Financial Report: Alkermes 2Q12 | November 03, 2011 | Contract Pharma |
| Alkermes reports loss following Elan merger | November 03, 2011 | Health News - BizJournals.com |
| Alkermes plc Reports Second Quarter Fiscal 2012 Financial Results | November 03, 2011 | Pharma News - Business Wire |
| Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2012 | October 27, 2011 | Pharma News - Business Wire |
| Alkermes Announces Initiation of Phase 2b Clinical Study of ALKS 37 for the Treatment of Opioid-Induced Constipation | October 03, 2011 | Pharma News - Business Wire |
| Progen Closes PG545 Phase 1a Clinical Trial; Alkermes Launches Corporate Operations in Ireland. | September 22, 2011 | Pharmaceutical - Moreover |
| Alkermes to Present at Jefferies 2011 Global Healthcare Conference | September 21, 2011 | Pharma News - Business Wire |
| Alkermes Buys Elan's EDT Unit | September 20, 2011 | Pharmaceutical - Moreover |
| Alkermes moves corporate HQ to Dublin | September 20, 2011 | Pharmaceutical - Moreover |
| Alkermes Launches Corporate Operations in Ireland | September 20, 2011 | Pharmaceutical - Moreover |
| Alkermes sets up operations in Ireland | September 20, 2011 | Pharmaceutical - Moreover |
| Flying high on Elan deal, Alkermes gets to work on Big Pharma project | September 19, 2011 | FiercePharma Manufacturing |
| Alkermes moves to Ireland and lands multimillion dollar manufacturing deal | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes (ALKS) Opens Dublin HQ, Enters Large Manufacturing Agreement | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes launches in Dublin and signs manufacturing deal | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes Integrates EDT, Announces Manufacturing Pact | September 19, 2011 | Contract Pharma |
| Alkermes establishes business operations in Ireland | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes eyes 1.1bn euro Dublin float | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes sets up shop in Ireland | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes plc Launches Corporate Operations in Ireland -- Company Establishes Headquarters in Dublin -- | September 19, 2011 | Pharmaceutical - Moreover |
| Alkermes plc Launches Corporate Operations in Ireland | September 19, 2011 | Pharma News - Business Wire |
| Alkermes plc and Elan Corporation plc Announce Completion of Merger Between Alkermes, Inc. and Elan Drug Technologies | September 16, 2011 | Biotech News - Business Wire |
| Alkermes shareholders approve Elan merger | September 08, 2011 | Health News - BizJournals.com |
| Alkermes shareholders approve Elan deal | September 08, 2011 | Health News - CNBC |
| Alkermes Announces Shareholder Vote in Favor of Merger with Elan Drug Technologies | September 08, 2011 | Pharma News - Business Wire |
| Alkermes exec netted $2.4M in stock sale after merger deal | August 12, 2011 | Health News - BizJournals.com |
| T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News | August 12, 2011 | Xconomy Life Sciences |
| Alkermes Reports First Quarter Fiscal 2012 Financial Results | August 01, 2011 | Pharma News - Business Wire |
| Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News | July 29, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes's BYDUREON Reply Submitted to FDA
| July 28, 2011 | BioSpace |
| Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2012 | July 25, 2011 | Pharma News - Business Wire |
| Alkermes Offers Post-Merger Vision; Aims to Join Big Biotech with Elan Corporation PLC Unit | July 19, 2011 | BioSpace |
| Alkermes - EDT merger to spark consolidation & strategic shift | July 19, 2011 | Pharmaceutical - Moreover |
| Alkermes CEO Pops is taking a run at the big league | July 19, 2011 | FierceBiotech |
| Alkermes Provides Outlook for Alkermes plc and Update on Advancing Product Portfolio at Analyst and Investor Day | July 18, 2011 | Biotech News - Business Wire |
| Elan Corporation PLC (ELN) to Close Pennsylvania Site Ahead of Unit Sale to Alkermes (ALKS), Terminating 1 | July 15, 2011 | Biotechnology - Moreover |
| Alkermes to Webcast Analyst and Investor Day | July 11, 2011 | Pharma News - Business Wire |
| Biotech Stocks: Amylin and Alkermes shine in drug-stocks trading | July 08, 2011 | Pharmaceutical - Moreover |
| Amylin and Alkermes shine in drug-stocks trading | July 08, 2011 | Biotechnology - Moreover |
| Amylin Pharmaceuticals, Inc., Alkermes Shares Jump on Success in Bydureon Study | July 08, 2011 | BioSpace |
| Amylin, Alkermes say diabetes drug safe for heart | July 07, 2011 | Health News - CNBC |
| Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA | July 07, 2011 | Xconomy Life Sciences |
| Alkermes Announces Results from Phase 2 Study of ALKS 33 for Treatment of Binge Eating Disorder | July 07, 2011 | Pharma News - Business Wire |
| Analysis: Alkermes aims at 'Big Biotech' status with EDT buyout | July 06, 2011 | FierceBiotech |
| Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” | July 06, 2011 | Xconomy Life Sciences |
| Alkermes (ALKS) Announces Positive Results from Clinical Study of ALKS 90 | June 30, 2011 | Biotechnology - Moreover |
| Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia | June 30, 2011 | Biotech News - Business Wire |
| Eli Lilly and Company, Alkermes and Amylin Pharmaceuticals, Inc. Announces BYDUREON(TM) Receives Marketing Authorization in Europe | June 21, 2011 | BioSpace - Breaking News |
| Alkermes stock rises on EU diabetes drug approval | June 21, 2011 | Health News - BizJournals.com |
| Amylin, Alkermes Diabetes Med OKd in EU | June 21, 2011 | Xconomy Life Sciences |
| Alkermes (ALKS) Initiates Clinical Study of ALKS 54 | June 15, 2011 | Biotechnology - Moreover |
| Alkermes (ALKS)' Corporate Presentation to be Webcast at the NASDAQ OMX | June 15, 2011 | Biotechnology - Moreover |
| Alkermes Initiates Clinical Study of ALKS 5461 for Treatment-Resistant Depression | June 15, 2011 | Pharma News - Business Wire |
| Analyst downgrades shares of Alkermes to 'average' | May 19, 2011 | Health News - CNBC |
| Alkermes loss widens; projects doubled sales in 2012 | May 19, 2011 | Health News - BizJournals.com |
| Alkermes Reports Financial Results for Fiscal 2011 and Provides Financial Expectations for Fiscal 2012 | May 18, 2011 | Pharma News - Business Wire |
| Elan Sells Drug Unit to Alkermes for $960M | May 12, 2011 | Burrill Report |
| Alkermes Rises 3% Ahead Of Earnings (ALKS) | May 12, 2011 | Biotechnology - Moreover |
| Alkermes (ALKS) to Host Conference Call to Discuss Fiscal Year 20 | May 12, 2011 | Biotechnology - Moreover |
| Alkermes to Host Conference Call to Discuss Fiscal Year 2011 Financial Results | May 11, 2011 | Pharma News - Business Wire |
| Varian Bought by Applied Materials, Nuance Picks Up Equitrac, Alkermes Pays $960M for Elan Unit, & More Boston-Area Deals News | May 11, 2011 | Xconomy Life Sciences |
| Alkermes (ALKS) Presents Phase 2 Data of ALKS | May 10, 2011 | Biotechnology - Moreover |
| Alkermes Presents Phase 2 Data of ALKS 37 in Late-Breaking Oral Session at | May 10, 2011 | BioSpace - Breaking News |
| Alkermes gains manufacturing strength with EDT pickup | May 09, 2011 | FiercePharma Manufacturing |
| Alkermes Presents Phase 2 Data of ALKS 37 in Late-Breaking Oral Session at Digestive Disease Week Meeting | May 09, 2011 | Clinical Trials - Business Wire |
| Cleary Gottlieb Reps Alkermes In $960M Elan Unit Buy | May 09, 2011 | Pharmaceutical - Moreover |
| Elan Sells Drug Technologies Business to Alkermes for $960M in Cash and Shares | May 09, 2011 | Inside Industry - Gen |
| Alkermes to acquire Elan unit in $960 million deal | May 09, 2011 | Health News - CNBC |
| Alkermes to acquire Elan division for $960M | May 09, 2011 | Health News - BizJournals.com |
| Alkermes: no Mass. job losses in merger | May 09, 2011 | Health News - BizJournals.com |
| Alkermes to Merge With Elan Drug Technologies | May 09, 2011 | Contract Pharma |
| Alkermes joins with Elan unit in $960M deal | May 09, 2011 | FiercePharma |
| Elan Sells Drug Delivery Business to Alkermes for $960M in Cash and Shares | May 09, 2011 | Inside Industry - Gen |
| Alkermes to buy Elan spin-off for $960M, re-incorporate in Ireland | May 09, 2011 | Health News - BizJournals.com |
| Elan Sells Formulation and Manufacturing Business to Alkermes for $960 in Cash and Shares | May 09, 2011 | Inside Industry - Gen |
| Alkermes buys Elan's delivery unit in $960M buyout deal | May 09, 2011 | FierceBiotech |
| Alkermes seals $960 million merger deal with Elan’s drug-delivery unit, to move HQ to Ireland | May 09, 2011 | Biotechnology - Moreover |
| UPDATE 1-Drugmaker Elan sells EDT unit to Alkermes for $960 mln | May 09, 2011 | Biotechnology - Moreover |
| Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc | May 09, 2011 | Pharma News - Business Wire |
| Alkermes Acquires Elan Drug Manufacturing Unit for $960M | May 09, 2011 | Xconomy Life Sciences |
| Alkermes Data on VIVITROL(R), the New FDA-Approved Medication for Prevention of Relapse to Opioid Dependence, Published in Lancet | April 28, 2011 | BioSpace - Breaking News |
| Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug | April 15, 2011 | Xconomy Life Sciences |
| Alkermes diabetes drug advances in Europe | April 15, 2011 | Health News - BizJournals.com |
| Alkermes shares nosedive on diabetes data | March 03, 2011 | Health News - BizJournals.com |
| Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study | March 03, 2011 | Xconomy Life Sciences |
| Alkermes Sees Chance to Reinvent Vivitrol For Fighting Drug Addiction, Not Just Alcoholism | February 18, 2011 | Xconomy Life Sciences |
| Alkermes says constipation drug met goal in study | February 15, 2011 | Health News - CNBC |
| Alkermes Announces Positive Preliminary Results from Phase 2 Study of ALKS 37 for Treatment of Opioid-Induced Bowel Dysfunction | February 15, 2011 | Pharma News - Business Wire |
| Alkermes (ALKS) Reports Third Quarter Fiscal | February 05, 2011 | Biotechnology - Moreover |
| Alkermes Reports Third Quarter Fiscal 2011 Financial Results | February 03, 2011 | Pharma News - Business Wire |
| Alkermes (ALKS) to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 20 | January 29, 2011 | Biotechnology - Moreover |
| Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2011 | January 27, 2011 | Pharma News - Business Wire |
| Alkermes Elects Wendy L. Dixon, Ph.D., to Board of Directors | January 18, 2011 | Pharma News - Business Wire |
| Alkermes spinout Civitas Therapeutics nabs $20M to fuel Parkinson's program | January 10, 2011 | FierceBiotech |
| Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout | January 10, 2011 | Xconomy Life Sciences |
| Alkermes (ALKS) Provides Update on Advancing Product Portfolio and Outlines Business Goals for | January 07, 2011 | Biotechnology - Moreover |
| Alkermes Provides Update on Advancing Product Portfolio and Outlines Business Goals for 2011 | January 07, 2011 | Pharma News - Business Wire |
| Alkermes Announces Results from Phase 2 Study of ALKS 33 in Alcohol Dependence | December 08, 2010 | Biotech News - Business Wire |
| Alkermes Presents Promising Preclinical Data on ALKS 33 for Multiple Disease Indications at Annual Meeting of the Society for Neuroscience | November 17, 2010 | Pharma News - Business Wire |
| Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box | November 15, 2010 | Xconomy Life Sciences |
| Alkermes posts smaller 2Q loss as revenue grows | November 04, 2010 | Health News - CNBC |
| Alkermes Reports Second Quarter Fiscal 2011 Financial Results | November 04, 2010 | Pharma News - Business Wire |
| Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2011 | October 28, 2010 | Pharma News - Business Wire |
| Alkermes addiction drug tests well | October 26, 2010 | Biotechnology - Moreover |
| Around the Region: Alkermes addiction drug tests well | October 26, 2010 | Biotechnology - Moreover |
| Alkermes addiction treatment meets study goal� 11 mins ago | October 25, 2010 | Biotechnology - Moreover |
| Alkermes addiction treatment meets study goal� 28 mins ago | October 25, 2010 | Biotechnology - Moreover |
| Alkermes addiction treatment meets study goal | October 25, 2010 | Health News - CNBC |
| Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of Cocaine Addiction | October 25, 2010 | Pharma News - Business Wire |
| Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News | October 22, 2010 | Xconomy Life Sciences |
| Lilly, Amylin, Alkermes Shares Get Crushed After FDA Rejects Diabetes Drug | October 20, 2010 | Pharmaceutical - Moreover |
| FDA Seeks More Data On Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Diabetes Drug | October 20, 2010 | BioSpace |
| Amylin, Alkermes Shares Crash on Surprise FDA Smackdown | October 20, 2010 | Xconomy Life Sciences |
| Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval | October 20, 2010 | Xconomy Life Sciences |
| Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ | October 19, 2010 | Pharma News - PR Newswire |
| FDA Approval Of Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes's Bydureon Diabetes Medicine Expected but Still Uncertain | October 18, 2010 | BioSpace |
| Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News | October 15, 2010 | Xconomy Life Sciences |
| Amylin, Alkermes Eagerly Await FDA Verdict (Again) For Once-Weekly Diabetes Drug | October 15, 2010 | Xconomy Life Sciences |
| Ahead of the Bell: Alkermes up on Vivitrol ruling | October 13, 2010 | Health News - CNBC |
| Alkermes Inc gets FDA approval for VIVITROL for opioid dependence | October 13, 2010 | Biotechnology - Moreover |
| The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication | October 13, 2010 | Pharma News - PR Newswire |
| Alkermes: FDA Widens Approved Use Of Vivitrol For Opioid Addiction | October 12, 2010 | Health News - Fox Business |
| Alkermes Gets Drug Approval | October 12, 2010 | Xconomy Life Sciences |
| Alkermes Announces FDA Approval of VIVITROL® for Prevention of Relapse to Opioid Dependence | October 12, 2010 | FDA News - Business Wire |
| Alkermes shares rise on FDA panel vote | September 17, 2010 | Health News - CNBC |
| Ahead of the Bell: Alkermes rises on Vivitrol vote | September 17, 2010 | Health News - CNBC |
| Alkermes: FDA panel OKs Vivitrol | September 16, 2010 | Health News - CNBC |
| Alkermes Wins FDA Panel Nod | September 16, 2010 | Xconomy Life Sciences |
| Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL® for Opioid Dependence | September 16, 2010 | FDA News - Business Wire |
| FDA review halts Alkermes trading | September 16, 2010 | Health News - BizJournals.com |
| Ahead of the Bell: Alkermes trading halted | September 16, 2010 | Health News - CNBC |
| Alkermes Stock Trading Halted Today | September 16, 2010 | FDA News - Business Wire |
| Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting for VIVITROL(R) for Opioid Dependence | September 14, 2010 | BioSpace - Breaking News |
| US FDA Cites Concerns with Alkermes Addiction Drug | September 14, 2010 | BioSpace |
| Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting for VIVITROL® for Opioid Dependence | September 14, 2010 | FDA News - Business Wire |
| Alkermes takes bigger 1Q loss on lower revenue | August 05, 2010 | Health News - CNBC |
| Alkermes Reports First Quarter Fiscal 2011 Financial Results | August 05, 2010 | Pharma News - Business Wire |
| Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2011 | July 29, 2010 | Pharma News - Business Wire |
| Alkermes Announces Notification of Tentative Alkermes Advisory Committee Meeting to Review VIVITROL(R) for Opioid Dependence | June 18, 2010 | BioSpace - Breaking News |
| Calls Purchased on Alkermes (ALKS) | June 18, 2010 | Biotechnology - Moreover |
| Amylin, Alkermes gain ground on Roche drug delay | June 18, 2010 | Health News - CNBC |
| Alkermes: FDA panel will review Vivitrol in Sept. | June 17, 2010 | Health News - CNBC |
| Alkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL® for Opioid Dependence | June 17, 2010 | FDA News - Business Wire |
| Alkermes Announces Priority Review by FDA for VIVITROL(R) for Opioid Dependence | May 25, 2010 | BioSpace |
| Alkermes Announces Priority Review by FDA for VIVITROL® for Opioid Dependence | May 25, 2010 | FDA News - Business Wire |
| Jesup & Lamont Initiates Coverage on Alkermes (ALKS) with a Buy | May 19, 2010 | Biotechnology - Moreover |
| Alkermes Release: Data on VIVITROL(R) to be Presented at Upcoming American Psychiatric Association Annual Meeting | May 19, 2010 | BioSpace - Breaking News |
| Alkermes Leads Drug Stocks Lower | May 14, 2010 | Health News - Fox Business |
| Alkermes takes bigger 4Q loss as revenue slips | May 13, 2010 | Health News - CNBC |
| Alkermes Reports Financial Results for Fiscal 2010 and Provides Financial Expectations for Fiscal 2011 | May 13, 2010 | FDA News - Business Wire |
| Alkermes diabetes drug gets second chance | May 06, 2010 | Health News - BizJournals.com |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Alkermes BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | May 06, 2010 | BioSpace - Breaking News |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Alkermes's BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | May 06, 2010 | BioSpace |
| Amylin, Alkermes Get New FDA Date | May 06, 2010 | Xconomy Life Sciences |
| Alkermes to Host Conference Call to Discuss Fiscal Year 2010 Financial Results | May 05, 2010 | Pharma News - Business Wire |
| Warner Bros. Acquires Turbine, Athenahealth Taps IBM, Alkermes Reveals Diabetes Drug Royalty, & More Boston-Area Deals News | April 28, 2010 | Xconomy Life Sciences |
| Alkermes to Provide Update on Advancing Product Portfolio and Proprietary Platforms at R&D Day | April 26, 2010 | Pharma News - Business Wire |
| Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug | April 26, 2010 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM); to Issue New PDUFA Target Date | April 23, 2010 | BioSpace |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM) | April 23, 2010 | BioSpace - Breaking News |
| Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM) | April 22, 2010 | Biotech News - PR Newswire |
| Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON™ | April 22, 2010 | FDA News - Business Wire |
| Alkermes to Webcast R&D Day on Monday, April 26, 2010 | April 19, 2010 | Pharma News - Business Wire |
| Alkermes Submits Supplemental New Drug Application for VIVITROL(R) for the Treatment of Opioid Dependence | April 13, 2010 | BioSpace - Breaking News |
| Alkermes Submits Supplemental New Drug Application for VIVITROL® for the Treatment of Opioid Dependence | April 13, 2010 | FDA News - Business Wire |
| Alkermes Files Drug App With FDA | April 13, 2010 | Xconomy Life Sciences |
| Alkermes starts drug trial for opiod users | March 17, 2010 | Health News - BizJournals.com |
| Alkermes Announces Initiation of Multidose Phase 1 Clinical Study of ALKS 37 for the Treatment of Opioid-Induced Constipation | March 17, 2010 | Pharma News - Business Wire |
| Alkermes shares pop on FDA's diabetes-drug response | March 15, 2010 | Health News - BizJournals.com |
| Amylin, Alkermes Diabetes Drug Delayed by FDA | March 15, 2010 | Xconomy Life Sciences |
| Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News | March 12, 2010 | Xconomy Life Sciences |
| Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug | March 10, 2010 | Xconomy Life Sciences |
| Alkermes drug application put on ice | February 25, 2010 | Health News - BizJournals.com |
| FDA Says "Snow" To Lilly, Amylin & Alkermes | February 25, 2010 | Health News - CNBC |
| Alkermes reports positive results from Phase I constipation study | February 17, 2010 | Biotechnology - Moreover |
| Alkermes Announces Positive Results for Phase 1 Study of New Drug Candidate for Treatment of Opioid-Induced Constipation | February 16, 2010 | Pharma News - Business Wire |
| Video: Alkermes CEO Sounds Off | February 08, 2010 | Biotechnology - Moreover |
| Alkermes reports 3Q loss, smaller than expected | February 05, 2010 | Health News - CNBC |
| Hapoalim Securities Upgrades Alkermes (ALKS) to Buy | February 05, 2010 | Biotechnology - Moreover |
| Drug Stocks Dip; Alkermes Jumps On Upgrade | February 05, 2010 | Health News - Fox Business |
| Ahead of the Bell: Alkermes upgraded on 3Q results | February 05, 2010 | Health News - CNBC |
| Alkermes Slips To Loss In Q4 As Revenues Plunged - Update | February 05, 2010 | Biotechnology - Moreover |
| Alkermes Reports Third Quarter Fiscal 2010 Financial Results | February 04, 2010 | Pharma News - Business Wire |
| Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders | February 04, 2010 | Pharma News - Business Wire |
| Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood | February 04, 2010 | Xconomy Life Sciences |
| Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2010 | January 28, 2010 | Pharma News - Business Wire |
| Victoza approval fuels share spike for Amylin, Alkermes | January 27, 2010 | FierceBiotech |
| Cash-rich Alkermes eyes new diseases | December 28, 2009 | Health News - BizJournals.com |
| Alkermes Inks $10M Licensing Deal with Acceleron Pharma | December 04, 2009 | BioSpace |
| Alkermes inks $10M licensing deal with Acceleron | December 03, 2009 | Health News - BizJournals.com |
| Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron | December 03, 2009 | Xconomy Life Sciences |
| Alkermes Licenses Technology Platform for Long-Acting Fusion Proteins from Acceleron Pharma | | Pharma News - Business Wire |
